Q4 FY2026 · ended Jun 30, 2026 · Revenue $34.51M, +1.9% YoY · Filed Sep 28, 2026
Natural Alternatives International, Inc. (NAII) files with the SEC under industry code 2833, Medicinal Chemicals & Botanical Products. In Q4 of fiscal 2026, the quarter ended Jun 30, 2026, it reported revenue of $34.5 million and a net loss of $13.5 million. Free cash flow was -$1.7 million. As of Jun 30, 2026 it held $7.4 million in cash and investments and $40.1 million in total debt.
Revenue
$34.51M
+1.9% vs year-ago quarter
Net income
$-13.54M
-87.6% vs year-ago quarter
Operating cash flow
$-1.07M
-131.9% vs year-ago quarter
Free cash flow
$-1.70M
-190.1% vs year-ago quarter
EPS
$-2.23
-85.5% vs year-ago quarter
Dividend per share
None
Shares outstanding
22.11M
+258.0% vs year-ago quarter
Net cash
$-32.76M
Q4 FY2026
Operating margin
-38.2%
Q4 FY2026
Company profile
- Industry
- Medicinal Chemicals & Botanical Products (SIC 2833)
- Listed as
- NAII (Nasdaq)
- Fiscal year ends
- June 30
- Incorporated in
- DE
- Headquarters
- Carlsbad, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 787253
Other Medicinal Chemicals & Botanical Products companies
- Definium Therapeutics, Inc. DFTX
- Regencell Bioscience Holdings Ltd RGC
- Curaleaf Holdings, Inc. CURLF
- Trulieve Cannabis Corp. TRLV
- Cronos Group Inc. CRON
- TFA Therapeutics, Inc. RAJAF
- Tilray Brands, Inc. TLRY
- SNDL Inc. SNDL
Key figures
Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.
| Line | Q4 FY2026 Jun 30, 2026 |
Q3 FY2026 Mar 31, 2026 |
Q2 FY2026 Dec 31, 2025 |
Q1 FY2026 Sep 30, 2025 |
Q4 FY2025 Jun 30, 2025 |
|---|---|---|---|---|---|
| Revenue | $34.5M | $35.5M | $34.8M | $37.7M | $33.9M |
| Operating income | -$13.2M | -$4.0M | -$1.8M | $284,000 | -$1.9M |
| Net income | -$13.5M | -$4.3M | -$2.6M | -$291,000 | -$7.2M |
| Diluted EPS | -$2.23 | -$0.72 | -$0.42 | -$0.05 | -$1.20 |
| Operating cash flow | -$1.1M | $2.5M | -$6.3M | -$4.0M | $3.3M |
| Free cash flow | -$1.7M | $1.4M | -$7.3M | -$5.1M | $1.9M |
| Total assets | $126.4M | $154.9M | $153.3M | $156.9M | $151.9M |
| Total liabilities | $76.5M | $91.8M | $86.3M | $87.9M | $83.5M |
| Stockholders' equity | $50.0M | $63.1M | $67.0M | $69.0M | $68.4M |
| Cash and investments | $7.4M | $9.2M | $3.8M | $7.7M | $12.3M |
| Total debt | $40.1M | $46.5M | $47.1M | $47.6M | $49.2M |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-K | Annual report | Sep 28, 2026 | Jun 30, 2026 |
| 10-Q | Quarterly report | May 19, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Officer or director change
|
May 1, 2026 | Apr 28, 2026 |
| 8-K |
Current report
Officer or director change
|
Mar 20, 2026 | Mar 18, 2026 |
| 10-Q | Quarterly report | Feb 13, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Material agreement
|
Dec 17, 2025 | Dec 17, 2025 |
All 777 Natural Alternatives International, Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.